Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid- (4'-trifluoromethylphenyl)-amide for treating inflammatory bowel disease

Details for Australian Patent Application No. 2005295511 (hide)

Owner Aventis Pharmaceuticals Inc.

Inventors Styren, Scot D.; Scheyer, Richard D.

Agent Watermark

Pub. Number AU-A-2005295511

PCT Pub. Number WO2006/044741

Priority 60/620,255 19.10.04 US

Filing date 18 October 2005

Wipo publication date 27 April 2006

International Classifications

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61P 1/00 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

Event Publications

10 May 2007 PCT application entered the National Phase

  PCT publication WO2006/044741 Priority application(s): WO2006/044741

12 May 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005295517-P27 ubiquitination assay and methods of use

2005295505-Method of preparing modified diallyl-N, N-disubstituted ammonium halide polymers